سعر فلكسوفان 20 كبسولة 250 مجم / 50 مجم 2024

Capsules of chlorzoxazone 250 mg + ketoprofen 50 mg (Flexofan, Amriya Pharmaceutical Industries), 20 capsules (2 strips).

• Chlorzoxazone: drowsiness, dizziness, lightheadedness, malaise; occasionally GI disturbance, rarely GI bleeding; urine may turn orange or purplish-red; rare allergic reactions.General active-ingredient information · DailyMed (U.S. NLM)

• Chlorzoxazone: known intolerance to the drug.General active-ingredient information · DailyMed (U.S. NLM)
• Ketoprofen: known hypersensitivity to ketoprofen or any component.General active-ingredient information · DailyMed (U.S. NLM)
• History of asthma, urticaria or allergic-type reactions after aspirin or other NSAIDs.General active-ingredient information · DailyMed (U.S. NLM)
• In the setting of coronary artery bypass graft (CABG) surgery.General active-ingredient information · DailyMed (U.S. NLM)

• Chlorzoxazone: serious (including fatal) hepatocellular toxicity has been reported rarely; stop and seek care if signs of liver dysfunction occur (fever, rash, anorexia, nausea, vomiting, fatigue, right upper quadrant pain, dark urine, jaundice).General active-ingredient information · DailyMed (U.S. NLM)
• Ketoprofen (NSAID) boxed warnings: increased risk of serious cardiovascular thrombotic events and of serious GI bleeding, ulceration and perforation.General active-ingredient information · DailyMed (U.S. NLM)

• Alcohol and other CNS depressantsChlorzoxazone may have additive CNS-depressant effects.DailyMed (U.S. NLM)

• NSAID component: avoid at about 30 weeks of gestation and later; limit use between about 20 and 30 weeks (fetal renal dysfunction/oligohydramnios, ductus arteriosus closure).General active-ingredient information · DailyMed (U.S. NLM)

• Chlorzoxazone: Acts primarily at the spinal cord and subcortical levels, inhibiting multisynaptic reflex arcs involved in muscle spasm (US label).
• Ketoprofen: Inhibits cyclo-oxygenase, reducing prostaglandin synthesis.